140 results match your criteria: "Steel Memorial Muroran Hospital.[Affiliation]"

Introduction: Compared to platinum-based therapies, a combination of ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) has demonstrated improved outcomes in advanced non-small cell lung cancer (NSCLC), albeit with higher rates of immune-related adverse events (irAEs). This multicenter retrospective study evaluated the efficacy and safety of nivolumab and ipilimumab with or without chemotherapy (NI and NICT) in real-world clinical settings.

Methods: We enrolled 215 treatment-naïve NSCLC patients who received NI or NICT between December 2020 and May 2023 at 14 institutions in Japan.

View Article and Find Full Text PDF

Background: In the first-line treatment of elderly patients with advanced-stage non-small cell lung cancer (NSCLC) with high programmed death-ligand 1 (PD-L1) expression (tumor proportion score ≥ 50%), this study aimed to determine whether pembrolizumab monotherapy (MONO) or pembrolizumab plus platinum-based chemotherapy (COMB) should be selected.

Methods: We performed a retrospective multicenter study (sub-analysis of the HOT/NJLCG2001 trial) of 299 patients with NSCLC with high PD-L1 expression who received MONO or COMB as the first-line treatment between December 2018 and January 2020. We selected patients aged 75 years and older and assessed the clinical efficacy and toxicity.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical amyopathic dermatomyositis is a skin condition that lacks muscle symptoms and is often associated with anti-melanoma differentiation-associated gene 5 antibodies, particularly in Japanese patients, leading to poor outcomes in those with lung complications.
  • A 52-year-old male presented with severe respiratory issues and skin rashes, diagnosed with dermatomyositis-related interstitial pneumonia, but treatment with steroids and immunosuppressants was largely ineffective.
  • Despite some initial improvement after switching medications, the patient ultimately faced worsening respiratory failure due to invasive pulmonary aspergillosis, resulting in a fatal outcome.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the effectiveness of different HPV sampling methods (physician, self, and urine) in predicting outcomes for patients with cervical intraepithelial neoplasia (CIN) grades 1-2, as this has not been previously reported.
  • - Conducted in Japan from October 2019 to November 2022, the research found that about 29.3% of CIN 1 cases and 50.0% of CIN 2 cases either progressed or persisted, with HPV-positive results from physician and self-collected samples significantly linked to CIN 1 progression.
  • - The findings emphasize the importance of physician- and self-testing for HPV in assessing CIN 1 progression risk, indicating a need for
View Article and Find Full Text PDF

Background: We clarified the predictive factors for changes in the status of medications for lower urinary tract symptoms (LUTS) 2 years after local radiotherapy for nonmetastatic prostate cancer.

Materials And Methods: We retrospectively included patients who underwent local external radiotherapy for nonmetastatic prostate cancer in 8 institutions between April 2001 and March 2016. Patients were divided into the medication and no-medication group based on the use of drugs for LUTS before radiotherapy.

View Article and Find Full Text PDF

In the 2010s, several unusual rotavirus strains emerged, causing epidemics worldwide. This study reports a comprehensive molecular epidemiological study of rotaviruses in Japan based on full-genome analysis. From 2014 to 2019, a total of 489 rotavirus-positive stool specimens were identified, and the associated viral genomes were analyzed by next-generation sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • The study assesses the long-term outcomes of patients with nonsmall cell lung cancer (NSCLC) and high PD-L1 expression treated with either pembrolizumab alone (MONO) or in combination with chemotherapy (COMB).
  • A total of 298 patients were observed, with COMB showing better overall survival (33.7 months) compared to MONO (17.2 months), although after adjusting for various factors, the advantage of COMB over MONO was not statistically significant.
  • The findings suggest that while COMB may be beneficial in certain patients, both treatment options have similar discontinuation rates, indicating comparable tolerability.
View Article and Find Full Text PDF

Objectives: Unresectable ampullary cancer (AC) is a rare disease entity. The risk factors for recurrent biliary obstruction (RBO) following endoscopic biliary stenting (EBS) for unresectable AC remain unknown. In this study we aimed to evaluate the cumulative RBO rate and to identify risk factors for RBO following palliative EBS in patients with unresectable AC.

View Article and Find Full Text PDF

Human adenovirus (HAdV) infections present diverse clinical manifestations upon infecting individuals, with respiratory infections predominating in children. We surveyed pediatric hospitalizations due to respiratory HAdV infections across 18 hospitals in Hokkaido Prefecture, Japan, from July 2019 to March 2024, recording 473 admissions. While hospitalizations remained below five cases per week from July 2019 to September 2023, a notable surge occurred in late October 2023, with weekly admissions peaking at 15-20 cases from November to December.

View Article and Find Full Text PDF

Hemidiaphragm paralysis, a complication of catheter ablation for atrial fibrillation, can severely affect respiratory function and can lead to paradoxical breathing and dyspnea on exertion. A 75-year-old woman with iatrogenic diaphragm paralysis showed improved symptoms, respiratory function, and exercise tolerance after video-assisted thoracoscopic diaphragm plication.

View Article and Find Full Text PDF

Purpose: To explore pre-treatment risk factors for overall survival (OS) in advanced urothelial carcinoma (UC) patients treated with first-line (1L) chemotherapy in sequential therapy (ST) era. Additionally, to evaluate the proportion of patients who were not able to undergo subsequent immune checkpoint inhibitor (ICI) therapy according to the subgroups stratified by the risk factors.

Methods: A multicenter retrospective study was conducted.

View Article and Find Full Text PDF

We report the case of a 76-year-old woman with an incomplete atrioventricular septal defect and severe congestive heart failure who underwent surgical repair. Surgical intervention involved mitral valve repair and patch closure of the ostium primum defect, resulting in a favorable postoperative course. Successful outcomes support surgery as a reasonable treatment option owing to its significant improvement in postoperative quality of life, even in elderly patients with left atrioventricular valve degeneration.

View Article and Find Full Text PDF

Prostatic hyperplasia is very common in elderly men and is a typical disease that reduces quality of life. Histologically, hyperplasia of the prostate gland causes obstruction at the bladder outlet, resulting in symptoms such as a weak urine stream. Various factors have been considered to cause histological enlargement of the prostate, but the underlying cause is still unknown.

View Article and Find Full Text PDF
Article Synopsis
  • A study compared the effectiveness of pembrolizumab and avelumab, two immune checkpoint inhibitors, in treating patients with advanced urothelial carcinoma who had previously undergone chemotherapy.
  • Researchers examined patient records from January 2018 to February 2023, focusing on progression-free survival, overall survival, and immune-related adverse events.
  • Results indicated no significant differences in survival outcomes between the two treatments, but pembrolizumab showed a potential risk for higher endocrine-related adverse effects compared to avelumab.
View Article and Find Full Text PDF
Article Synopsis
  • Durvalumab has been used in patients with unresectable stage III non-small cell lung cancer (NSCLC), but its effectiveness for those with epidermal growth factor receptor (EGFR) mutations is still uncertain.
  • A study analyzed 673 patients who received chemoradiotherapy (CRT), finding 51 with EGFR mutations; those patients showed a higher percentage of females and never-smokers.
  • Both EGFR-positive and negative groups exhibited similar progression-free survival rates post-durvalumab treatment, with pneumonitis being the most common adverse effect, suggesting durvalumab may be a viable option for EGFR-positive patients.
View Article and Find Full Text PDF

Endoscopic ultrasound-guided gallbladder drainage for patients with cholecystitis and high surgical risk is commonly performed by dilating the fistula before inserting the delivery sheath; however, this carries an increased risk of peritonitis. To overcome this problem, we developed a new technique that did not require dilation, using a 0.035-inch stiff guidewire, and retrospectively evaluated the efficacy and safety of this technique.

View Article and Find Full Text PDF

Background: Due to the lack of studies, the long-term prognoses of unfit patients with gastric cancer (GC) who did not receive any aggressive cancer treatment (best supportive care [BSC] cases) remain unclear, especially for those with potentially curable GC. We conducted this observational study to capture the real-world data of characteristics and outcomes for BSC cases.

Method: Consecutive clinical records of patients with GC diagnosed at Steel Memorial Muroran Hospital from January 2017 to December 2021 were analyzed.

View Article and Find Full Text PDF

Following the coronavirus disease 2019 (COVID-19) outbreak in February 2020, incidences of various infectious diseases decreased notably in Hokkaido Prefecture, Japan. However, Japan began gradually easing COVID-19 infection control measures in 2022. Here, we conducted a survey of children hospitalized with human metapneumovirus (hMPV), influenza A and B, and respiratory syncytial virus infections in 18 hospitals across Hokkaido Prefecture, Japan, spanning from July 2019 to June 2023.

View Article and Find Full Text PDF

A 50-year-old man with a history of total gastrectomy, distal pancreatectomy, splenectomy, and Roux-en-Y reconstruction was admitted to our hospital with a gallbladder tumor that had infiltrated the liver and abdominal wall. Because malignant cells were not collected during the percutaneous biopsy, we planned to perform an endoscopic ultrasound-guided fine-needle biopsy with a 22-G Franseen needle using a forward-viewing echoendoscope. Using intermittent manual compression, the forward-viewing echoendoscope reached the duodenum under fluoroscopic guidance.

View Article and Find Full Text PDF

Background: Accumulating evidence has demonstrated platinum-based chemotherapy followed by maintenance therapy with a poly Adenosine diphosphate (ADP)-ribose polymerase inhibitor (olaparib) show benefits in unresectable pancreatic cancer with a germline (g)BRCA1/2 mutation. Evaluation of the germline BRCA1 and BRCA2 mutation is essential for making decisions on a treatment strategy for patients with unresectable pancreatic cancer. However, the detection rates of germline BRCA1 and BRCA2 mutations and efficacy of maintenance with olaparib remain undetermined, prospectively, in Japan.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess how effective local radiation therapy (LRT) is in preventing local symptoms associated with muscle-invasive bladder cancer (MIBC) by reviewing 133 patient records over five years.
  • Out of 114 patients analyzed, 26.3% experienced local symptoms such as hematuria and bladder pain, with certain risk factors like previous non-MIBC and lower radiation doses identified.
  • The findings suggest that increasing the radiation dose to 50 Gray or more could help reduce these local symptoms and improve care strategies for MIBC patients expected to have good survival outcomes.
View Article and Find Full Text PDF

After previous earthquakes, high prevalence of cardiovascular diseases including venous thromboembolism (VTE) has been reported. We performed venous screening at the site of Hokkaido East Iburi Earthquake which happened at 6th September 2018. VTE screening using ultrasound sonography was performed for total 7 days at Atsuma town, Mukawa town and Abira town (total 9 shelters).

View Article and Find Full Text PDF

Ipilimumab plus nivolumab therapy is approved for patients with unresectable advanced esophageal squamous cell carcinoma (ESCC). Although a combination of immune checkpoint inhibitors (ICIs), compared to conventional chemotherapy, can improve overall survival in patients with advanced ESCC, this increases the incidence of immune-related adverse events (irAEs). Here, we describe an ESCC case that developed pemphigus vulgaris (PV), an extremely rare cutaneous irAE, during ipilimumab plus nivolumab treatment.

View Article and Find Full Text PDF